Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Ramonell

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Blood Advances|November 18, 2022
Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral loadDevon J Eddins, Junkai Yang, Astrid Kosters, et al.
BMJ Open|February 5, 2025
Impact of glucocorticoids on patients' quality of life: a qualitative study assessing face validity and feasibility of the Steroid PRO in patients with inflammatory gastroenterology, respiratory and dermatology conditionsAnne-Marie T Sweeney, Susan Bridgewater, Jen Orme, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2023
CCL5 is a potential bridge between type 1 and type 2 inflammation in asthmaMarc Gauthier, Sagar Laxman Kale, Timothy B Oriss, et al.
Science Translational Medicine|November 6, 2024
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19Benjamin R Babcock, Astrid Kosters, Devon J Eddins, et al.
Nature Communications|July 14, 2023
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVIDMatthew C Woodruff, Kevin S Bonham, Fabliha A Anam, et al.
International Forum of Allergy & Rhinology|May 1, 2025
Allergic Fungal Rhinosinusitis Diagnosis, Management, Associated Conditions, Pathophysiology, and Future Directions: Summary of a Multidisciplinary WorkshopLauren T Roland, Cecelia Damask, Amber U Luong, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 InfectionNatalie S Haddad, Doan C Nguyen, Merin E Kuruvilla, et al.
Nature|August 31, 2022
Dysregulated naive B cells and de novo autoreactivity in severe COVID-19Matthew C Woodruff, Richard P Ramonell, Natalie S Haddad, et al.
Nature Immunology|October 8, 2020
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19Matthew C Woodruff, Richard P Ramonell, Doan C Nguyen, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2024
Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunityMartin C Runnstrom, Pedro A Lamothe, Caterina E Faliti, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Blood Advances|November 18, 2022
Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral loadDevon J Eddins, Junkai Yang, Astrid Kosters, et al.
BMJ Open|February 5, 2025
Impact of glucocorticoids on patients' quality of life: a qualitative study assessing face validity and feasibility of the Steroid PRO in patients with inflammatory gastroenterology, respiratory and dermatology conditionsAnne-Marie T Sweeney, Susan Bridgewater, Jen Orme, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2023
CCL5 is a potential bridge between type 1 and type 2 inflammation in asthmaMarc Gauthier, Sagar Laxman Kale, Timothy B Oriss, et al.
Science Translational Medicine|November 6, 2024
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19Benjamin R Babcock, Astrid Kosters, Devon J Eddins, et al.
Nature Communications|July 14, 2023
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVIDMatthew C Woodruff, Kevin S Bonham, Fabliha A Anam, et al.
International Forum of Allergy & Rhinology|May 1, 2025
Allergic Fungal Rhinosinusitis Diagnosis, Management, Associated Conditions, Pathophysiology, and Future Directions: Summary of a Multidisciplinary WorkshopLauren T Roland, Cecelia Damask, Amber U Luong, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 InfectionNatalie S Haddad, Doan C Nguyen, Merin E Kuruvilla, et al.
Nature|August 31, 2022
Dysregulated naive B cells and de novo autoreactivity in severe COVID-19Matthew C Woodruff, Richard P Ramonell, Natalie S Haddad, et al.
Nature Immunology|October 8, 2020
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19Matthew C Woodruff, Richard P Ramonell, Doan C Nguyen, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2024
Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunityMartin C Runnstrom, Pedro A Lamothe, Caterina E Faliti, et al.
Pageof 4